Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27697267

Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck

Author
SCHMITZ, S1 2 ; HAMOIR, M2 ; LONNEUX, M5 ; CAPPOEN, N1 ; GILLAIN, A1 ; MACHIELS, J.-P1 2 ; REYCHLER, H3 ; MAGREMANNE, M3 ; WEYNAND, B4 ; LHOMMEL, R5 ; HANIN, F.-X5 ; DUPREZ, T6 ; MICHOUX, N6 ; ROMMEL, D6
[1] Cancer Center, Department of Medical Oncology, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), Universite catholique de Louvain, Brussels, Belgium
[2] Department of Head and Neck Surgery, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium
[3] Department of Oral and Maxillofacial Surgery, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium
[4] Department of Anatomopathology, Université catholique de Louvain, Cliniques universitaires Saint-Luc and CHU Mont-Godinne, Brussels, Yvoir, Belgium
[5] Department of Nuclear Medicine, Université catholique de Louvain, Brussels, Belgium
[6] Department of Medical Imaging and Radiology, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium
Source

Annals of oncology. 2013, Vol 24, Num 9, pp 2261-2266, 6 p ; ref : 15 ref

ISSN
0923-7534
Scientific domain
Medical oncology; Pharmacology drugs
Publisher
Oxford University Press, Oxford
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
cetuximab head and neck cancer targeted therapy
Keyword (fr)
Anticancéreux Cancer de la tête et du cou Carcinome épidermoïde de la tête et du cou Cétuximab Homme Thérapeutique ciblée Toxicité Traitement Anti-EGFR Réponse tumorale Anticorps monoclonal Cancer Pathologie ORL Récepteur facteur croissance épiderme Tumeur maligne
Keyword (en)
Antineoplastic agent Head and neck cancer Head and neck squamous cell carcinoma Cetuximab Human Targeted therapy Toxicity Treatment Tumor response Monoclonal antibody Cancer ENT disease Epidermal growth factor receptor Malignant tumor
Keyword (es)
Anticanceroso Cáncer de cabeza y cuello Carcinoma epidermoideo cabeza cuello Cetuximab Hombre Terapéutica dirigida Toxicidad Tratamiento Respuesta tumoral Anticuerpo monoclonal Cáncer ORL patología Receptor del factor de crecimiento epidérmico Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors / 002B04C Multiple tumors. Solid tumors. Tumors in childhood (general aspects)

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B10 Otorhinolaryngology. Stomatology / 002B10A Otorhinolaryngology (head neck, general aspects and miscellaneous) / 002B10A01 Tumors

Discipline
Otorhinolaryngology. Stomatology Pharmacological treatments Tumours
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
27697267

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web